UroGen Pharma Ltd. short interest in 2022
In 2022, UroGen Pharma Ltd.'s disclosed short interest ran from 8.23% of shares outstanding on 14 Jan 2022 to 2.91% on 30 Dec 2022, a change of -5.32 percentage points. The year's high was 10.77% on 31 May 2022 and its low 2.91% on 30 Nov 2022, averaging 7.09% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.14 days on 30 Sep 2022. Full history: UroGen Pharma Ltd..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 8.23% (14 Jan 2022)
- End of year
- 2.91% (30 Dec 2022)
- Change
- -5.32 pp
- High
- 10.77% (31 May 2022)
- Low
- 2.91% (30 Nov 2022)
- Average
- 7.09%
- Highest days to cover
- 36.14 (30 Sep 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.23% | 13.61 | |
| 31 Jan 2022 | 8.89% | 10.36 | |
| 15 Feb 2022 | 8.90% | 23.15 | |
| 28 Feb 2022 | 9.86% | 18.57 | |
| 15 Mar 2022 | 9.81% | 16.20 | |
| 31 Mar 2022 | 8.85% | 14.83 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 9.22% | 15.21 | |
| 29 Apr 2022 | 10.17% | 14.62 | |
| 13 May 2022 | 10.39% | 13.75 | 10-Q filed, results (8-K) |
| 31 May 2022 | 10.77% | 10.65 | |
| 15 Jun 2022 | 9.60% | 14.06 | |
| 30 Jun 2022 | 7.50% | 4.60 | |
| 15 Jul 2022 | 6.71% | 20.20 | |
| 29 Jul 2022 | 6.50% | 28.09 | |
| 15 Aug 2022 | 6.43% | 24.76 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 6.21% | 33.69 | |
| 15 Sep 2022 | 6.29% | 29.34 | |
| 30 Sep 2022 | 6.09% | 36.14 | |
| 14 Oct 2022 | 4.86% | 12.96 | |
| 31 Oct 2022 | 3.30% | 9.36 | |
| 15 Nov 2022 | 2.94% | 8.93 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 2.91% | 11.15 | |
| 15 Dec 2022 | 2.91% | 13.41 | |
| 30 Dec 2022 | 2.91% | 11.72 |
See also: UroGen Pharma Ltd.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.